Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Sanofi Agrees To Sell European Generics Unit To Advent For $2.2B

By Mike Botta | June 29, 2018

Sanofi has concluded negotiations leading to Advent International‘s acquisition of Zentiva, Sanofi’s European generics business for €1.9 billion ($2.2 billion). The companies had entered into exclusive talks in April.

Headquartered in Prague, Zentiva provides access across Europe to a broad generics portfolio covering a variety of therapeutic areas. The company reaches more than 40 million patients in 25 European countries and focuses on three European generics market areas—pharmacy, physician, and wholesaler. Zentiva’s operates flexible manufacturing facilities in Prague and Bucharest.

Advent, a private equity firm founded in 1984, has invested in more than 335 private equity transactions in 41 countries through March of this year and had €33 billion ($39 billion) in assets under management. The firm’s investments in the pharmaceutical and health sector since 1994 included:

  • Syneos Health, Inc. (U.S.) services to biopharma companies (formerly Inc. Research); 2016, buyout
  • Genoa Healthcare (U.S.) specialty pharmacy operator; 2015, buyout
  • Mediq (Netherlands) pharmaceuticals provider; 2013, public-to-private
  • Grupo Biotoscana (Columbia) company marketing products in Latin America; 2011, buyout
  • Laboratorio LKM (Argentina) specialty pharmaceutical manufacturer (acquired by Grupo Biotoscana); 2011, buyout
  • Labormed (Romania) pharma manufacturer and distributor(acquired by Alvogen); 2008, buyout
  • Terapia (Romania) generic drug manufacturer; 2003, public-to-private
  • Aviagen (U.K.) health and biosecurity in meat/poultry supply; 2003, buyout
  • Viatris (Germany) developer, manufacturer, distributor branded pharma; 2002, buyout
  • Fada Pharma (Argentina) generic pharmaceutical maker for institutional market; 2001, buyout
  • Tropon (Germany) toll manufacturer and supplier of drugs; 2000, buyout
  • Alcala Farma (Spain) manufacturer of branded generics and OTC products; 1999, growth equity
  • Trinity Pharmaceuticals (U.K.) co-developer and marketer of branded pharma; 1997, buyout
  • Managed Healthcare Associates (U.S.) contract services to long-term-care pharmacies; 1997, buyout
  • 3i-Implant Innovations Inc. (U.S.) maker of dental implants; 1995, growth equity
  • Telik (U.S.) pharma developer (merged with MabVax); 1994, growth equity
  • Esaote Biomedica (Italy) research, production, marketing of diagnostic equipment; 1994, buyout
  • Transcend Therapeutics (U.S.) critical-care pharmaceutical developer; 1994, growth equity

The signing of the Share Purchase Agreement between Sanofi and Advent marks a key step toward the closing of the deal and the transfer of the Zentiva business anticipated during the fourth quarter of 2018. The transaction remains subject to the approval of regulatory authorities. 

(Source: Sanofi)

Related Articles Read More >

A Zipline fixed-wing drone in the air drops a package
Cardinal Health starts Zipline drone deliveries of drugs and medical supplies
Pfizer logo
Pfizer to spend $120M to make COVID-19 oral treatment in U.S.
Image of MedTrace Pharma's P3 automated delivery system for 15-O water in action
MedTrace Pharma moves forward on 15 O-water imaging tech
coronavirus COVID-19 Pfizer
NIH starts evaluating second COVID-19 booster shots in adults

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards